POMx In the Treatment of Erectile Dysfunction
NCT01220206 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2012-10-05
Summary
POMx can be used as a treatment for erectile dysfunction.
Conditions
Interventions
- DRUG
-
2 placebo capsules daily
- DRUG
-
One POMx capsule daily
One POMx capsule, one placebo capsule daily
- DRUG
-
2 POMx Capsules
2 POMx Capsules daily
Sponsors & Collaborators
-
Target Health Inc.
collaborator INDUSTRY -
POM Wonderful LLC
lead INDUSTRY
Principal Investigators
-
James McMurray, MD · Medical Affiliated Research Center, Inc.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Max Age
- 70 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-08-31
- Primary Completion
- 2012-10-31
- Completion
- 2012-10-31
Countries
- United States
Study Locations
More Related Trials
-
Efficacy and Safety of TPN171H in the Patients With Erectile Dysfunction
NCT04479917 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacodynamic Study of TPN171H Tablets in Patients With Mild to Moderate Erectile Dysfunction
NCT05388825 ·Status: COMPLETED ·Phase: PHASE2
-
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE)
NCT03055806 ·Status: COMPLETED ·Phase: PHASE2
-
Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintaining an Erection and Sexual Quality of Life
NCT00422734 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Onset, Safety & Toleration of UK-369,003 in Male Erectile Dysfunction
NCT00141349 ·Status: COMPLETED ·Phase: PHASE2
-
Proof of Concept Study on BP1.4979 Effect on Primary Premature Ejaculation
NCT07047404 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction
NCT05650866 ·Status: RECRUITING ·Phase: NA
-
A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation
NCT01021553 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Trial of SK3530 in Erectile Dysfunction
NCT00351065 ·Status: TERMINATED ·Phase: PHASE2
-
Assessment of Efficacy and Safety of UK-390,957 in Men With Premature Ejaculation
NCT00143117 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Clinical Trial to Evaluate the Efficacy and Safety of DA-8031 in Male Patients With Premature Ejaculation
NCT01798667 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Semen Characteristics After 9 Months of Daily Tadalafil 20 mg
NCT00382135 ·Status: COMPLETED ·Phase: PHASE4
-
A Study On Concentrations Of 16448 In Blood And The Safety Of This Compound In Healthy Males With Premature Ejaculation
NCT00537459 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial of Topically-applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction (ED)
NCT02495467 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Tadalafil on the Quality of Life and Sexual Life in Erectile Dysfunction
NCT00422578 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Evaluation of Effectiveness and Safety of Dietary Supplement Potensa in Men With Erectile Dysfunction
NCT03039504 ·Status: COMPLETED ·Phase: NA
-
Phase III Study to Assess the Efficacy and Safety of SK3530 in Patients With Erectile Dysfunction and Hypertension
NCT00644007 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Erectile Dysfunction II
NCT01037218 ·Status: COMPLETED ·Phase: PHASE3
-
Therapeutic Outcomes of Selective Serotonin Reuptake Inhibitors and Phosphodiesterase-5 Inhibitors Combination Therapy Versus Monotherapy
NCT07057011 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Open Label Study to Evaluate the Effect of Kaempferia Parviflora in Support of Erectile Function and Male Sexual Health
NCT03389867 ·Status: COMPLETED ·Phase: NA
-
Efficacy, Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment Premature Ejaculation
NCT00556478 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction
NCT06968494 ·Status: RECRUITING ·Phase: NA
-
PSD502 in Subjects With Premature Ejaculation
NCT03578783 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2A Clinical Trial Evaluating the Potential Activity and Safety of hMaxi-K Gene for ED
NCT02713789 ·Status: COMPLETED ·Phase: PHASE2
-
Observational Study of Pharmacological Treatment for Premature Ejaculation Concurrent With Erectile Dysfunction
NCT04361305 ·Status: UNKNOWN ·Phase: PHASE3